Pfizer coronavirus vaccine revenue is projected to hit $26 billion in 2021 with production surge

“Pfizer has emerged as a leader in mRNA development, and we are exploring a wide range of opportunities for the technology,” chief executive Albert Bourla said Tuesday in a conference call for investors. Without disclosing specifics, he said the company is working on other vaccines for infectious diseases as well as creating a research pipeline for therapeutics for cancer and genetic diseases.

Source: WP